Barbara J. Gitlitz

Gene Therapy Laboratory — France

Medicine · Health Sciences

44h-index8.3kcitations194works2.62yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Lung Cancer Treatments and Mutations(84), Cancer Immunotherapy and Biomarkers(38), Lung Cancer Research Studies(24), Lung Cancer Diagnosis and Treatment(22), Renal cell carcinoma treatment(18)

Publications193 total

Abstract C038: Impact of assessment schedules on atezolizumab anti-drug antibody incidence rates
Cancer Immunology Research·2026
Reply to: “Improving the Reporting of Long-Term Effects in the IMpower010 Trial” and “Adjuvant Atezolizumab in Early-Stage Non-Small Cell Lung Cancer: Signals, Silences, and the Need for Methodological Clarity”
Journal of Clinical Oncology·2025
OA02.01 SKYSCRAPER-05: Phase II Study of Perioperative Tiragolumab + Atezolizumab ±Chemotherapy in Locally Advanced Resectable NSCLC
Journal of Thoracic Oncology·2025
Brief Report: Post Hoc Validation of Platinum Ineligibility in NSCLC From the Phase III IPSOS Study
Journal of Thoracic Oncology·2025· 2 cited
Phase 3 Trials of Neoadjuvant, Perioperative, and Adjuvant Chemoimmunotherapy for Resectable, Early-Stage NSCLC: Comprehensive Review and Detailed Analysis
JTO Clinical and Research Reports·2025Open Access
Five-Year Survival Outcomes With Atezolizumab After Chemotherapy in Resected Stage IB-IIIA Non–Small Cell Lung Cancer (IMpower010): An Open-Label, Randomized, Phase III Trial
Journal of Clinical Oncology·2025· 22 citedOpen Access
A plain language summary of atezolizumab compared with single-agent chemotherapy in participants with non-small cell lung cancer who should not receive platinum-based chemotherapy (the IPSOS study)
Future Oncology·2025Open Access
409P: IMpower010: Digital pathology (DP) vs manual SP263 PD-L1 tumour cell (TC) scoring on whole imaging slides from patients (pts) with stage II-IIIA PD-L1 TC ≥50% NSCLC
Journal of Thoracic Oncology·2025· 1 citedOpen Access
EP.01A.01 Role of Diet and Exercise in Young Lung Cancer Patients with Driver Mutations (NCT04640259)
Journal of Thoracic Oncology·2024Open Access
Improved efficacy of pembrolizumab combined with soluble EphB4-albumin in HPV-negative EphrinB2 positive head neck squamous cell carcinoma
Oncotarget·2024· 2 citedOpen Access
Abstract CT239: IMpower010: Updated overall survival and safety results from Asian patients in a Phase III study of adjuvant atezolizumab vs best supportive care in resected stage IB-IIIA NSCLC
Cancer Research·2024· 2 cited
P2.31-02 Real-World Survival Outcomes in NSCLC in Adults Ages 50 and Younger at a Large Academic Institution
Journal of Thoracic Oncology·2023Open Access
EP11.02-06 Atezolizumab vs Single-Agent Chemo in NSCLC Patients Ineligible for a 1L Platinum Regimen: Asian Subgroup Analysis of IPSOS
Journal of Thoracic Oncology·2023Open Access
OA13.06 The Epidemiology of Young Lung Cancer: Interim Analysis of Risk Factors and Genetic Mutations
Journal of Thoracic Oncology·2023Open Access
Comparison of SP263 and 22C3 immunohistochemistry PD-L1 assays for clinical efficacy of adjuvant atezolizumab in non-small cell lung cancer: results from the randomized phase III IMpower010 trial
Journal for ImmunoTherapy of Cancer·2023· 14 citedOpen Access
IMpower010: Exploratory analysis of disease-free survival by KRAS status in patients with stage II-IIIA NSCLC treated with adjuvant atezolizumab vs best supportive care.
Journal of Clinical Oncology·2023· 4 cited
Data from <i>EGFR</i> Fusions as Novel Therapeutic Targets in Lung Cancer
2023Open Access
Supplementary Figures S1 - S10 from <i>EGFR</i> Fusions as Novel Therapeutic Targets in Lung Cancer
2023Open Access
Supplementary Tables S1 - S3 from <i>EGFR</i> Fusions as Novel Therapeutic Targets in Lung Cancer
2023Open Access
Supplementary Figures S1 - S10 from <i>EGFR</i> Fusions as Novel Therapeutic Targets in Lung Cancer
2023Open Access
page 1 of 10Next →

Frequent Co-authors

Robert A. Figlin(19), Arie S. Belldegrun(17), Amnon Zisman(10), Allan J. Pantuck(10), David R. Gandara(8), Debby H. Chao(7), Jonathan Said(6), Fredrick Dorey(5), Jean B. deKernion(5), Suresh S. Ramalingam(5), Marianna Koczywas(5), Chandra P. Belani(5), Nancy P. Moldawer(5), Heather A. Wakelee(4), Vincent A. Miller(4), Everett E. Vokes(4), Karen L. Reckamp(4), C L Tso(4), Siraj M. Ali(4), Enriqueta Felip(3)